More than a billion Nemera devices are sold every year across 54 countries. Our solutions cover different routes: ophthalmic to address glaucoma and dry eye disease, ENT for allergic rhinitis and breakthrough cancer pain, Parenteral for hormonal disorders such as diabetes and infertility, Dermal for skin indications such as psoriasis, eczema, acnes and hair loss and Inhalation notably to treat asthma and COPD.